Phone: 94 601 5696
Email: asier.fullaondo@ehu.es
Office Location: School of Science and Technology,Room: F1.P0.6
Research Group: MOLECULAR BIOLOGY OF CANCER
Personal Web Pages:

• Genetika Medikuntza Fakultatean
• E2F ikerketa taldea
• Genetika Medikuntza
• ORCID ID
• Scopus ID

I began my University teaching in 1995. During this time, I have participated in teaching the subjects of Genetics (compulsory) and Cytogenetics and Human Genetics (optional) in the Degree of Medicine, at the School of Medicine and Dentistry.Currently, I am a lecturer at the School of Science and Technology and teach the subjects ofGenetics in the Degree of Biology, and Genomics in the Degrees of Biochemistry and Molecular Biology and Biotechnology.

Regarding post-graduate teaching, I am one of the lecturers in the courses Fundamentals of Genomics, Proteomics and Bioinformatics and Proteomikaren Oinarriak. These courses are part of the Master in Molecular Biology and Biomedicine.

In addition, I supervise graduate student projects in the Degree of Biology and the Degree of Biochemistry. I also supervise master student projects within the Master in Molecular Biology and Biomedicine.

I received my Ph.D. in 1999 with a study on "Genetic characterization of the potato cyst nematode".
I did my postdoctoral stay at the Netherlands Proteomic Center, where I specialized in proteomic analysis applied to cell proliferation and differentiation processes. My research is linked to the research line directed by Dr. Ana Zubiaga, mainly focused on the genetic regulation of cell cycle and tumor development. Besides, I have participated in other research lines related to the analysis of genotoxicity.

Pascual-Itoiz MA, Peña-Cearra A, Martín-Ruiz I, Lavín JL, Simó C, Rodríguez H, Atondo E, Flores JM, Carreras-González A, Tomás-Cortázar J, Barriales D, Palacios A, García-Cañas V, Pellón A, Fullaondo A, Aransay AM, Prados-Rosales R, Martín R, Anguita J, Abecia L. The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis. Sci Rep. 2020 Jan 17;10(1):572. doi: 10.1038/s41598-019-57348-0.

Peñalver-Gonzalez B, Vallejo-Rodriguez J, Mentxaka G, Fullaondo A, Iglesias-Ara A, Field SJ, Zubiaga AM. Golgi Oncoprotein GOLPH3 Gene Expression Is Regulated by Functional E2F and CREB/ATF Promoter Elements. Genes (Basel). 2019 Mar 25;10(3). pii: E247. doi: 10.3390/genes10030247.

Valcárcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, García-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H; REGISTRY investigators of the European Huntington’s Disease Network (EHDN), Zubiaga AM, Aguirre A. Does arterial hypertension influence the onset of Huntington's disease? PLoS One. 2018 May 23;13(5):e0197975. doi: 10.1371/journal.pone.0197975. 

Mitxelena* J, Apraiz* A, Vallejo-Rodríguez* J, García-Santisteban I, Fullaondo A, Alvarez-Fernández M, Malumbres M, Zubiaga AM. (* equal contribution). An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability. Nucleic Acids Res. 2018 May 18;46(9):4546-4559. doi:10.1093/nar/gky218.

Prieto G, Fullaondo A, Rodríguez JA. (2016) Proteome-wide search for functional motifs altered in tumors: Prediction of nuclear export signals inactivated by cancer-related mutations.  Sci Rep. 2016 May 12;6:25869. 

Valcárcel-Ocete L, Alkorta-Aranburu G, Iriondo M, Fullaondo A, García-Barcina M, Fernández-García JM, Lezcano-García E, Losada-Domingo JM, Ruiz-Ojeda J, Álvarez de Arcaya A, Pérez-Ramos JM, Roos RA, Nielsen JE, Saft C; REGISTRY investigators of the European Huntington's Disease Network, Zubiaga AM, Aguirre A.(2015)  Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene. PLoS One. 2015 Jul 6;10(7):e0131573